Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection.
Saved in:
| Title: | Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. |
|---|---|
| Authors: | Ricciardi MJ; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA.; George Washington University, 2121 I St. NW, Washington, DC 20052, USA., Rust LN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Pedreño-Lopez N; George Washington University, 2121 I St. NW, Washington, DC 20052, USA.; IrsiCaixa AIDS Research Institute, Ctra. del Canyet SN, Badalona 08916, Barcelona, Spain., Yusova S; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Biswas S; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Webb GM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Gonzalez-Nieto L; Miller School of Medicine, University of Miami, Miami, FL 33136, USA., Voigt TB; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA.; George Washington University, 2121 I St. NW, Washington, DC 20052, USA., Louw JJ; George Washington University, 2121 I St. NW, Washington, DC 20052, USA., Laurino FD; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA., DiBello JR; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA., Raué HP; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA., Barber-Axthelm AM; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA., Chun K; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA., Uttke S; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA., Raphael LMS; Laboratório de Biologia Molecular de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Yrizarry-Medina A; George Washington University, 2121 I St. NW, Washington, DC 20052, USA., Rosen BC; Miller School of Medicine, University of Miami, Miami, FL 33136, USA., Agnor R; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA., Gao L; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA., Labriola C; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA., Axthelm M; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA., Smedley J; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA., Julander JG; Institute for Antiviral Research, Utah State University, Logan, UT 84322, USA., Bonaldo MC; Laboratório de Biologia Molecular de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Walker LM; Adagio Therapeutics Inc., Waltham, MA 02451, USA., Messaoudi I; Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington, KY 40536, USA., Slifka MK; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA., Burton DR; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA., Kallas EG; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA.; Department of Infectious and Parasitic Diseases, School of Medicine, University of Sao Paulo, Sao Paulo, Brazil., Sacha JB; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA.; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA., Watkins DI; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA.; George Washington University, 2121 I St. NW, Washington, DC 20052, USA., Burwitz BJ; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA. |
| Source: | Science translational medicine [Sci Transl Med] 2023 Mar 29; Vol. 15 (689), pp. eade5795. Date of Electronic Publication: 2023 Mar 29. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1946-6242 |
|---|---|
| DOI: | 10.1126/scitranslmed.ade5795 |
